Inhibitory Effect of M50054, a Novel Inhibitor of Apoptosis, on Anti-Fas-Antibody-Induced Hepatitis and Chemotherapy-Induced Alopecia

    December 2001 in “ European Journal of Pharmacology
    Toshihiko Tsuda, Youko Ohmori, Hiroyuki Muramatsu, Yoshitaka Hosaka, Kazuhiko Takiguchi, Fumihiko Saitoh, Kazuo Kato, Kazuyuki Nakayama, Norio Nakamura, Shigekazu Nagata, Hidenori Mochizuki
    TLDR M50054 may help treat hepatitis and hair loss from chemotherapy.
    M50054, a novel inhibitor of apoptosis, was found to inhibit cell death in human Fas-expressing WC8 cells and U937 leukemia cells by blocking caspase-3 activation. This compound effectively reduced apoptotic features such as DNA fragmentation and phosphatidylserine exposure. In animal models, M50054 significantly improved symptoms of anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia. These findings suggested that M50054 could be a potential treatment for conditions like hepatitis and hair loss caused by chemotherapy.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results